Moderna pivots to infectious disease & oncology, targeting cash break-even by 2028. Click here to see why I rate MRNA stock a ...

Dr Melanie Ivarsson was on Monday named chief executive of the Health Data Research Service (HDRS), which will give ...

Moderna CEO Stéphane Bancel positions 2026 as a catalyst-rich year driven by new vaccine launches, late-stage oncology data, ...

Moderna said on Monday it expects to report around $1.9  billion in sales for 2025, putting it near the upper end of its ...

Expects 2025 revenue of approximately $1.9 billion (unaudited), $100 million above midpoint communicated on 3Q25 Earnings ...

Caterpillar CAT stock rose toward closing with a market cap of more than $300 billion for the first time ever, according to ...

Moderna shares are volatile Monday after the company provided updates on its business and pipeline at a healthcare conference ...

At the 44 th Annual JP Morgan Healthcare Conference on Monday, Moderna Inc. (NASDAQ:MRNA) said that it expects to report ...

Moderna reiterated its plan to deliver up to 10% revenue growth in 2026 while further reducing operating expenses. The ...

Former Moderna executive Dr Melanie Ivarsson has been appointed chief executive of the UK's Health Data Research Service ...

JPMorgan Chase falls after quarterly profit at the bank declines 7%.

Stocks that are trending today. Stéphane Bancel, CEO of Moderna , said: "We remain focused on our strategy to build a large ...